Denali Therapeutics Inc. (DNLI) stock
Close on Nov 12, 2026Market cap $3.02BP/E –Yield –
Denali Therapeutics statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.77
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 5.81%
- 10.9%
- Shares Change (QoQ)
- 0.69%
- 0.51%
- Float
- 149M
- 49M
- Shares Held by Insiders
- 6.64%
- 12.1%
- Shares Held by Institutions
- 97.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 15M
- –
- Short Interest Change
- -5.04%
- -0.76%
- Short % of Float
- 9.85%
- 9.04%
- Short % of Shares Outstanding
- 9.19%
- 6.30%
- Days to Cover
- 9.91
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $27.30
- –
- 52-Week Low
- $15.34
- –
- 20-Day Moving Average
- $19.18
- –
- 50-Day Moving Average
- $19.86
- –
- 200-Day Moving Average
- $21.24
- –
- Average True Range (14)
- $0.91
- –
- Price Change (1 Week)
- -4.21%
- 1.51%
- Price Change (1 Month)
- 5.71%
- -2.35%
- Price Change (3 Months)
- -22.6%
- -21.1%
- Price Change (6 Months)
- -2.58%
- -22.6%
- Price Change (YTD)
- 14.4%
- -22.6%
- Price Change (1 Year)
- 7.45%
- -20.7%
- Price Change (3 Years)
- 16.6%
- -27.4%
- Price Change (5 Years)
- -62.8%
- -77.3%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.80
- 0.79
- Relative Strength Index (14)
- 44.6
- 44.7
- Volatility (1 Year)
- 54.0%
- 80.4%
- Beta (5 Years)
- 1.66
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -54.9%
- -51.2%
- Return on Assets (ROA)
- -44.0%
- -40.6%
- Return on Invested Capital (ROIC)
- -343.4%
- -32.9%
- Return on Capital Employed (ROCE)
- -50.8%
- -38.0%
Financial positionIndustry
- Current Ratio
- 8.37
- 3.30
- Quick Ratio
- 7.93
- 2.42
EfficiencyIndustry
- Profits Per Employee
- -$1.02M
- -$683.67K
- Employee Count
- 503
- 75
- WACC
- 13.3%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $710.47M
- $17.46M
- Net Cash Per Share
- $4.44
- $0.72
- Equity (Book Value)
- $835.18M
- $53.27M
- Book Value Per Share
- $5.22
- $1.50
- Tangible Book Value
- $799.93M
- $26.82M
- Working Capital
- $663.84M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$3.42M
- -$944.00K
- FCF Per Share
- -$2.74
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -16.9%
- -20.8%
- FCF Yield
- -14.5%
- -9.58%
Scores and fair valueIndustry
- Altman Z-Score
- 1.96
- 0.30
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | DNLI | S&P 500 | Difference | DNLI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.3% | -2.7% | +2.4 pts | ||
| 3 months | -25.2% | -1.7% | −23.5 pts | ||
| Year to date | +14.4% | +11.9% | +2.5 pts | ||
| 1 year | +7.8% | +12.0% | −4.2 pts | ||
| 3 years | +16.5% | +78.2% | −61.7 pts | +5.2% | +21.2% |
| 5 years | -62.8% | +73.2% | −136.0 pts | -17.9% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
15M DNLI shares were sold short on Oct 30, 2026, down 5.0% from the previous report, or 9.85% of the shares available to trade. At recent volumes it would take 9.9 days to buy them back. Over the last 20 sessions, 42.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 14,694,882 | -5.0% | 1,483,329 | 9.9 |
| Oct 15, 2026 | 15,475,322 | +0.1% | 1,918,379 | 8.1 |
| Sep 30, 2026 | 15,463,975 | -9.8% | 2,023,714 | 7.6 |
| Sep 15, 2026 | 17,139,415 | +3.0% | 1,431,794 | 12.0 |
| Aug 31, 2026 | 16,642,362 | -7.3% | 951,216 | 17.5 |
| Aug 14, 2026 | 17,959,465 | +3.0% | 1,446,971 | 12.4 |
| Jul 31, 2026 | 17,434,654 | +8.7% | 1,438,878 | 12.1 |
| Jul 15, 2026 | 16,035,916 | +0.5% | 1,910,758 | 8.4 |
| Jun 30, 2026 | 15,949,089 | +3.5% | 2,295,382 | 7.0 |
| Jun 15, 2026 | 15,407,744 | +2.8% | 1,827,145 | 8.4 |
| May 29, 2026 | 14,990,471 | +6.9% | 1,870,118 | 8.0 |
| May 15, 2026 | 14,026,925 | -5.3% | 1,867,525 | 7.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?